Caplin Point Laboratories shares gained 2 percent in the opening trade on January 28 after the company received final approval from the United States Food and Drug Administration (USFDA) for its ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of Cincinnati's best-funded ...
Forbes contributors publish independent expert analyses and insights. AI researcher working with the UN and others to drive social change. Dec 01, 2025, 07:08am EST Hacker. A man in a hoodie with a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Zalunfiban is an investigational platelet inhibitor that ...
The 22-year NBA veteran is just 1 point shy of reaching 50,000 career points – regular season and playoffs combined. Brian Martin, for NBA.com LeBron James is averaging 24.8 points with the Lakers ...
Luka Doncic is the 6th player to reach 10,000 points before turning 25, reaching that point on a 3-pointer vs. Phoenix. From NBA.com News Services Luka Doncic knocks down a 34-foot 3-pointer in the ...
Generating effective protection against HIV may require a complex vaccine consisting of a series of different viral proteins. Now, two trials of the potential components delivered via mRNA have ...
Packed with the highest concentration of pure hyaluronic acid (HA) Profhilo is a bio-remodeling treatment that subtly lifts, firms, and leaves a natural glow on skin. Profhilo treatments are quick, ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results